Ana Markovic

Dr. Ana Markovic

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
IJIvan Jeremic
Ivan Jeremic
MBMilan Bogojevic
Milan Bogojevic
ZVZoran Mile Veličković
Zoran Mile Veličković
MZMirjana Zlatkovic-Svenda
Mirjana Zlatkovic-Svenda
Goran RadunovicGoran Radunovic
Goran Radunovic
Background: The European League Against Rheumatism (EULAR), in collaboration with the European Scleroderma Trial and Research group (EUSTAR), published the first set of treatment recommendations for systemic sclerosis (SSc) in 2009, with subsequent updates in 2016 and 2023. Objectives: This study aimed to evaluate how rheumatologists’ clinical approaches to the treatment of SSc evolved following the 2016 update of the clinical management guidelines. Methods: Medication use for SSc was analyzed in a cohort of 378 patients. The patients were stratified based on enrollment before (233 patients) and after (145 patients) the guideline update, and medication usage was compared between the two groups. Results: Although all patients presented with Raynaud’s phenomenon (RP), only 35% received calcium channel blockers. Medications such as iloprost, phosphodiesterase type 5 (PDE-5) inhibitors, fluoxetine, and bosentan, recommended for the treatment of RP and digital ulcers, were not approved for SSc by the Republic Health Insurance Fund. Treatment for pulmonary arterial hypertension (PAH) was administered to only 16 patients (4.2%), including 2 who received bosentan, 10 who received PDE-5 inhibitors, and 4 who were treated with riociguat. The use of PDE-5 inhibitors increased following the 2016 update of the guidelines. Cyclophosphamide was consistently prescribed for interstitial lung disease (ILD), with an increased frequency observed after the guideline update. No significant differences were observed in the use of methotrexate for skin involvement, ACE inhibitors for scleroderma renal crisis, or antibiotics for gastrointestinal symptoms. Proton pump inhibitors (PPIs) were prescribed to 87.3% of patients with gastrointestinal involvement, with an increase in use of both PPIs and prokinetic agents following the guideline update. Conclusions: Rheumatologists’ adherence to the EULAR/EUSTAR guidelines varied considerably, with 25% to 100% of eligible patients receiving the recommended treatments. Concordance improved in the management of PAH, ILD, and gastrointestinal involvement after the 2016 guideline update.

1 January 2025 in Medicinska istrazivanja
Verified
Journal Article
Open access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
MBMilan Bogojevic
Milan Bogojevic
DPDragana Pravilović-Lutovac
Dragana Pravilović-Lutovac
MZMirjana Zlatkovic-Svenda
Mirjana Zlatkovic-Svenda
AMAna Markovic
Ana Markovic
Goran RadunovicGoran Radunovic
Goran Radunovic
Introduction: Capillaroscopy is a non-invasive diagnostic tool used to detect morphological abnormalities in the microcirculation. The assessment of capillaroscopic findings in healthy subjects is likely the area where controversies are most difficult to resolve. This review focuses on capillary architecture in healthy individuals across different age groups. Methods: A search was conducted in PubMed, MEDLINE, and Scopus using the following terms: capillaroscopy, healthy subjects, Raynaud's phenomenon, microcirculation, and microvascular abnormalities. A total of 10 relevant articles were identified. Results: The shape of capillaries and the architecture of the nailfold microvascular network can vary significantly among healthy individuals. The most commonly observed abnormalities in this population include tortuosity, crossovers, homogeneously enlarged loops, neoangiogenic capillaries, and microbleeding. Less frequently, more unusual patterns, such as ramified, bushy, or glomerular loops may be observed. These atypical features require careful evaluation to avoid missing a potential underlying disease. Conclusion: This review critically examines capillaroscopy findings in healthy individuals, taking into account typical nail care practices and age-related changes. These insights may assist clinicians in distinguishing physiological variations from early signs of microvascular damage.

1 January 2026 in Medicinska rec
Verified
Journal Article
Open access
PDF file
SJSaša Janjić
Saša Janjić
AĐAna Đokić
Ana Đokić
MĐMilena Đokić
Milena Đokić
AMAna Markovic
Ana Markovic
APAnđela Peruničić
Anđela Peruničić
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
Reactive arthritis (ReA) is an immune-mediated, aseptic arthritis that may develop within a period ranging from 3 days to 6 weeks following any extra-articular infection. Although it is most commonly precipitated by gastrointestinal or genitourinary infections, in the aftermath of the SARS-CoV-2 pandemic, increasing attention has been directed toward the role of respiratory pathogens in the development of this condition. Accordingly, the aim of this review is to present current knowledge regarding rare respiratory pathogens associated with ReA, with particular emphasis on their clinical relevance and diagnostic and therapeutic implications. A systematic search of the relevant scientific literature was conducted using the Medline database, with a particular focus on the period from 2020 to 2025, in order to identify and analyze cases of ReA occurring in the context of respiratory infections, primarily those caused by rare respiratory pathogens. The analysis included individual case reports, original research articles, and review papers documenting the occurrence of ReA following respiratory infections. The most frequently identified respiratory pathogens were SARS-CoV-2, Chlamydophila pneumoniae, Streptococcus pyogenes, Parvovirus B19, and Mycoplasma pneumoniae, with a variable time interval between infection and the onset of arthritis (ranging from several days to several weeks). Less common respiratory pathogens included Streptococcus pneumoniae, Neisseria meningitidis, Rothia mucilaginosa, Haemophilus influenzae, and Mycobacterium tuberculosis. The clinical presentation of ReA associated with these pathogens did not differ substantially from that of typical etiologies; however, differences were observed in symptom duration and therapeutic response. In most cases, arthritis was oligoarticular, asymmetric, and accompanied by systemic signs of inflammation. Therapeutic approaches included nonsteroidal anti-inflammatory drugs, corticosteroids, and, in selected cases, antibiotics and immunosuppressive agents. ReA triggered by rare respiratory pathogens represents a diagnostic challenge. Although these pathogens are less frequently identified, their role in the etiopathogenesis of ReA warrants additional attention, given the potential for an atypical disease course and the need for individualized therapeutic strategies. The limited number of available case reports and other scientific publications highlights the need for further research and for the standardization of diagnostic criteria in this field.